Journal of Cell Communication and Signaling

Papers
(The H4-Index of Journal of Cell Communication and Signaling is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
The opposite effect of ELP4 and ZEB2 on TCF7L2‐mediated microglia polarization in ischemic stroke55
tRNA-derived fragments (tRFs) in cancer54
BLM promotes malignancy in PCa by inducing KRAS expression and RhoA suppression via its interaction with HDGF and activation of MAPK/ERK pathway44
Proteome‐wide assessment of human interactome as a source of capturing domain–motif and domain‐domain interactions34
Metastases from metastases: comparative metastatic potential of human cancer cell lines originated from primary tumors or metastases in various tissues29
The advance of CCN3 in fibrosis28
Ephrin–Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies27
Calcium sensing receptor stimulates breast cancer cell migration via the Gβγ-AKT-mTORC2 signaling pathway24
The network map of urotensin-II mediated signaling pathway in physiological and pathological conditions24
Farewell Springer… Hello Wiley23
Severe heat stress modulated nuclear factor erythroid 2-related factor 2 and macrophage migration inhibitory factor pathway in rat liver22
The network map of Elabela signaling pathway in physiological and pathological conditions21
Integrin α11β1 in tumor fibrosis: more than just another cancer-associated fibroblast biomarker?19
A multi-cellular molecular signaling and functional network map of C–C motif chemokine ligand 18 (CCL18): a chemokine with immunosuppressive and pro-tumor functions18
Dehydrozingerone promotes healing of diabetic foot ulcers: a molecular insight18
Dual impacts of mesenchymal stem cell-derived exosomes on cancer cells: unravelling complex interactions16
Novel role of long non-coding RNAs in autoimmune cutaneous disease16
ROR2 promotes epithelial-mesenchymal transition by hyperactivating ERK in melanoma16
0.079468011856079